<DOC>
	<DOCNO>NCT01310322</DOCNO>
	<brief_summary>A study healthy subject mild asthmatic investigate Pharmacokinetics AZD5423 administer different way .</brief_summary>
	<brief_title>A Study Healthy Subjects Mild Asthmatics Investigate Pharmacokinetics AZD5423 When Administered Different Ways</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Male healthy subject male asthma patient age 18 45 year ( inclusive ) Have body mass index ( BMI ) 18 30 kg/m2 ( inclusive rounding allow ) weight 50 100 kg ( inclusive ) Be able inhale SPIRA nebuliser Ineb® accord provide instruction Asthma patient fulfil follow criterion : Prebronchodilator force expiratory volume 1 second ( FEV1 ) ≥70 % predict normal value Asthma diagnosis accord GINA guideline history episodic wheeze shortness breath History clinically significant disease disorder Any clinically relevant abnormal finding Current smoker Asthma patient : Worsening asthma respiratory infection within 6 week screen Asthma patient : Use inhale , nasal , oral , rectal parenteral corticosteroid within 30 day first administration investigational product study</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Phase I</keyword>
	<keyword>Healthy male volunteer</keyword>
	<keyword>mild asthmatic</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>Bioavailability AUC</keyword>
	<keyword>Level AZD5423 blood</keyword>
</DOC>